Today: 20 May 2026
Amazon stock price today: AMZN dips as investors weigh AWS AI content plan and pharmacy delivery expansion
11 February 2026
1 min read

Amazon stock price today: AMZN dips as investors weigh AWS AI content plan and pharmacy delivery expansion

NEW YORK, February 11, 2026, 10:01 EST — Regular session

Amazon.com, Inc. (AMZN) dropped 0.7% to $205.43 in Wednesday morning action. Shares hovered near session lows after an early move just over $209.

The retreat follows a notable surge from retail investors, who piled in during the latest dip. On Friday, Amazon saw its largest one-day net retail buying since August 2024, Vanda Research told Reuters.

But those purchases haven’t put the bigger question to rest: just how much cash Amazon will need to spend before AI demand starts making a clear impact on earnings. Last week, Amazon put investors on notice with plans for roughly $200 billion in capital expenditures—money earmarked for things like data centers and chips—in 2026. That revelation sent the stock lower. “The market just dislikes the substantial amount of money that keeps getting put into capex for these growth rates,” said Dave Wagner, portfolio manager at Aptus Capital Advisors. Reuters

Reuters, referencing The Information, said Tuesday that Amazon Web Services has floated the idea of a marketplace letting publishers sell content to AI product makers. According to the report, AWS presentation slides, prepared for a publisher event, pitched the concept of a content marketplace alongside Bedrock and Quick Suite, its main AI offerings. Amazon’s spokesperson told Reuters there’s “nothing specific to share.” Reuters

Amazon flagged another push into healthcare logistics, saying its pharmacy arm will roll out same-day prescription delivery to roughly 4,500 U.S. cities and towns this year—nearly 2,000 more communities getting access. The move follows Amazon’s 2018 PillPack acquisition, an October partnership with WeightWatchers targeting delivery of prescriptions like injectable GLP-1 obesity drugs, and December’s launch of prescription kiosks at One Medical clinics.

Stocks found some footing as the SPDR S&P 500 ETF added 0.5%. QQQ, which tracks the Nasdaq, was up around 0.7%. Microsoft slipped close to 1%, and Alphabet was also down, but just slightly.

Still, the core question about Amazon’s multiple isn’t answered by the AI marketplace or pharmacy push. These ventures might need a while before they really deliver reliable revenue. If Amazon gets spending wrong — say, building out too much too soon — that’s going to hit margins before any growth materializes.

The rates backdrop has rattled big tech stocks this month, and traders aren’t losing sight of it. Friday’s U.S. January consumer price numbers hit at 8:30 a.m. ET—a drop that could jolt rate expectations again.

Next up: the Federal Reserve releases minutes from its Jan. 27-28 meeting on Feb. 18. Amazon’s situation adds another layer—investors are pushing to see if the publisher-content marketplace becomes more than just talk and presentations, and if it does, who actually calls the shots on pricing.

Stock Market Today

  • Value of $1000 Investment in Comfort Systems After 10 Years
    May 20, 2026, 9:54 AM EDT. A $1000 investment in Comfort Systems USA (FIX) made 10 years ago would have grown significantly, reflecting the company's strong performance and sector presence. Comfort Systems provides mechanical and electrical contracting services nationwide, focusing on HVAC, plumbing, electrical systems, and fire protection. With 2025 revenues driven 73.3% by Mechanical services and 26.7% by Electrical, the company manages over 8,000 projects valued at $26.39 billion as of March 31, 2026. Its backlog increased to $12.45 billion, up from $6.89 billion a year earlier, underpinning solid future revenue recognition. The firm operates 190 locations across 142 U.S. cities, serving commercial and institutional markets. Long-term investors in FIX have benefited from the company's diversified project base and strong contract pipeline, illustrating the importance of research, patience, and risk management in building successful portfolios.

Latest articles

TJX Stock Jumps Before the Bell After T.J. Maxx Owner Lifts Profit View

TJX Stock Jumps Before the Bell After T.J. Maxx Owner Lifts Profit View

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
AmpliTech Jumps After 5G Approval Clears North America Sales Path

AmpliTech Jumps After 5G Approval Clears North America Sales Path

20 May 2026
AmpliTech received U.S. and Canadian certification for its full indoor 5G Native DAS hardware, enabling immediate commercial sales and integration across North America. Shares rose about 14% in premarket trading after the announcement. The company said it has orders from a North American mobile network operator, with shipments set to begin later this year.
Accenture stock drops as CEO share-sale filing and $1.4 billion contract protest hit tape
Previous Story

Accenture stock drops as CEO share-sale filing and $1.4 billion contract protest hit tape

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 12.02.2026

Go toTop